share_log
Reuters ·  May 13 08:28
CRISPR Therapeutics AG : Morgan Stanley Raises Target Price to $50.00 From $48.00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment